Clinical Trial Update: A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE) [Phase 2]

View source ↗

Summary

Phase 2 VERSE trial evaluating Lebrikizumab in patients with uncontrolled asthma on inhaled corticosteroids plus a second controller; the study status is COMPLE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED